1958 University of Michigan Football Team

1959 University of Michigan Football Team

University of Michigan Football Team, 1958

Front Row, Left to Right: Thomas DeMassa, James Sytek, Jack Zachary, Robert Wojcik, Jerry Leith, Harry Newman, Jr., Dave Brown, James McPherson, Alvin Groce, Grant Walls, John Halstead, Joseph Brefeld, Richard Syring, Phil Barger, Wilfrid Grein, John Galarneault.

Second Row: Coach Don Dufek, John Batsakes, Paul Poulos, Fred Olm, Dennis Fitzgerald, Jim Byers, Doug Oppman, Robert Ptacek, John Herrnstein, Gary Prahst, Walt Johnson, Gerald Marciniak, Willie Smith, Anthony Rio, Michael Dupay, Mike Fillichio, Bob Johnson, Jim Dickey, Coach Matt Patanelli.

Third Row: Coach Jack Blott, Coach Bob Hollway, James Gray, Maynard Stetten, Gordon Morrow, Eugene Sisinyak, Guy Curtis, B. Lee Hall, Darrell Harper, Jared Bushong, Alex Callahan, Wesley Maki, Donald Kolcheff, Fred Julian, George Genyk, Gerald Smith, Robert Swanson, Willerfred Wilson, Erwin Crownley, Coach Ben Oosterbaan.

Back Row: Coach Wally Weber, Reid Bushong, Gary McNitt, Bill Stein, Tom Jobson, Donald Hannah, Gary Kane, John Walker, Willard Hildebrand, Paul Raeder, Darrell Thorpe, Daniel Snow, Thomas Kerr, Lovell Farris, David Palomaki, Bradley Myers, Donald Deskins, Arthur Lazik, John Spidel, Keith Cowan, Henry Stuart, Coach "Bump" Elliott.

University of Michigan Football Team, 1958

Front Row, Left to Right: Thomas DeMassa, James Sytek, Jack Zachary, Robert Wojcik, Jerry Leith, Harry Newman, Jr., Dave Brown, James McPherson, Alvin Groce, Grant Walls, John Halstead, Joseph Brefeld, Richard Syring, Phil Barger, Wilfrid Grein, John Galarneault.

Second Row: Coach Don Dufek, John Batsakes, Paul Poulos, Fred Olm, Dennis Fitzgerald, Jim Byers, Doug Oppman, Robert Ptacek, John Herrnstein, Gary Prahst, Walt Johnson, Gerald Marciniak, Willie Smith, Anthony Rio, Michael Dupay, Mike Fillichio, Bob Johnson, Jim Dickey, Coach Matt Patanelli.

Third Row: Coach Jack Blott, Coach Bob Hollway, James Gray, Maynard Stetten, Gordon Morrow, Eugene Sisinyak, Guy Curtis, B. Lee Hall, Darrell Harper, Jared Bushong, Alex Callahan, Wesley Maki, Donald Kolcheff, Fred Julian, George Genyk, Gerald Smith, Robert Swanson, Willerfred Wilson, Erwin Crownley, Coach Ben Oosterbaan.

Back Row: Coach Wally Weber, Reid Bushong, Gary McNitt, Bill Stein, Tom Jobson, Donald Hannah, Gary Kane, John Walker, Willard Hildebrand, Paul Raeder, Darrell Thorpe, Daniel Snow, Thomas Kerr, Lovell Farris, David Palomaki, Bradley Myers, Donald Deskins, Arthur Lazik, John Spidel, Keith Cowan, Henry Stuart, Coach "Bump" Elliott.

A distributed equivalent magnetic current based FDTD method for the calculation of E-fields induced by gradient coils

This paper evaluates a new, low-frequency finite-difference time-domain method applied to the problem of induced E-fields/eddy currents in the human body resulting from the pulsed magnetic field gradients in MRI. In this algorithm, a distributed equivalent magnetic current is proposed as the electromagnetic source and is obtained by quasistatic calculation of the empty coil's vector potential or measurements therein. This technique circumvents the discretization of complicated gradient coil geometries into a mesh of Yee cells, and thereby enables any type of gradient coil modelling or other complex low frequency sources. The proposed method has been verified against an example with an analytical solution. Results are presented showing the spatial distribution of gradient-induced electric fields in a multi-layered spherical phantom model and a complete body model. (C) 2004 Elsevier Inc. All rights reserved.

The reliability and validity of the Therapeutic activity index

Purpose To assess the psychometric properties of the Simplified Therapeutic Intervention Scoring System (TISS 28) scale. Materials and Methods A prospective observational design was used. Patients were recruited from a medical-surgical intensive care unit (ICU) and 4 rehabilitation wards of 2 university-affiliated hospitals in Hong Kong. Results Data necessary for the calculation of the TISS 28, the Therapeutic Intervention Scoring System (TISS 76), and severity of illness scoring system (Simplified Acute Physiology Score [SAPS II]) were recorded for each patient during the first 24 hours after his/her admission to an ICU. A significant positive correlation was found between the TISS 76 and the TISS 28 scores as well as the TISS 28 and the SAPS II scores. There was a significant difference between the TISS 28 scores among ICU patients and patients in rehabilitation wards. A significant correlation was found between the TISS 28 scores of the first and second set of TISS 28 scores. Conclusions Although the findings supported the validity and reliability of the TISS 28, there were limitations of the TISS 28 in measuring nursing workload in ICUs. Hence, continued amendment and validation of the TISS 28 on larger samples in different ICUs would be required so as to provide clinical nurses with a valid and reliable assessment of nursing workload.

Perinatal outcomes with laser surgery for twin-twin transfusion syndrome

The aim of this tertiary hospital-based cohort study was to determine and compare perinatal outcome and neonatal morbidities of pregnancies with twin-twin transfusion syndrome (TTTS) before and after the introduction of a treatment program with laser ablation of placental communicating vessels. Twenty-seven pregnancies with Stage II-IV TTTS treated with amnioreduction were identified (amnioreduction group). The data were compared with that obtained from the first 31 pregnancies with Stage II-IV TTTS managed with laser ablation of placental communicating vessels (laser group). Comparisons were made for perinatal survival and neonatal morbidities including abnormalities on brain imaging. The median gestation at therapy was similar between the two groups (20 vs. 21 weeks, p = .24), while the median gestation at delivery was significantly greater in the laser treated group (34 vs. 28 weeks, p = .002). The perinatal survival rate was higher in the laser group (77.4% vs. 59.3%, p = .03). Neonatal morbidities including acute respiratory distress, chronic lung disease, requirement for ventilatory assistance, patent ductus arteriosus, hypotension, and oliguric renal failure had a lower incidence in the laser group. On brain imaging, ischemic brain injury was seen in 12% of the amnioreduction group and none of the laser group of infants (p = .01). In conclusion, these findings indicate that perinatal outcomes are improved with less neonatal morbidity for monochorionic pregnancies with severe TTTS treated by laser ablation of communicating placental vessels when compared to treatment by amnioreduction.

Hepatic pharmacokinetics of propranolol in rats with adjuvant-induced systemic inflammation

Systemic inflammation is known to affect drug disposition in the liver. This study sought to relate and quantitate changes in hepatic pharmacokinetics of propranolol with changes in hepatic architecture and physiology in adjuvant-treated rats. Transmission electron microscopy was used to assess morphological changes in mitochondria and lysosomes of adjuvant-treated rat livers. The disposition of propranolol was assessed in the perfused rat liver using the multiple indicator dilution technique. Hepatic extraction and mean transit time were determined from outflow-concentration profiles using a nonparametric method. Kinetic parameters were derived from a two-phase physiologically based organ pharmacokinetic model. Possible relationships were then explored between the changes in hepatic drug disposition and cytochrome P-450 activity and iron concentration. Adjuvant treatment induced the appearance of mitochondrial inclusions/tubularization and irregularly shaped lysosomes in rat livers. Livers from adjuvant-treated rats had (relative to normal) significantly higher alpha(1)-acid glycoprotein (orosomucoid) and iron tissue concentrations but lower cytochrome P-450 content. The hepatic extraction, metabolism, and ion trapping of propranolol were significantly impaired in adjuvant-treated rats and could be correlated with altered iron store and cytochrome P-450 activity. It is concluded that adjuvant-induced systemic inflammation alters hepatocellular morphology and biochemistry and consequently influences hepatic disposition of propranolol.